I have sent my questions:
@mannkindcorp: Please send your questions for our earnings call next Monday August 7th to ir@mannkindcorp.com and we will address as many as possible!
1. I would like to know more about international market expansion ambitions for Afrezza: Brazil, India, China, UAE, and Europe.
2. I would like the company to update which R&D partnerships are still active, in particular OneDrop and Receptor Life Sciences (RLS). Read more:
mnkd.proboards.com/thread/8191/partnerships#ixzz4oVXdUhpJ3. Locust Walk for Technosphere: Any updates?
4. Greenhill advising on financial options: Any updates?
5. VDEX: Any updates?
5. TV Commercial / Reversed: Is the company planning on reaching out to more celebrities? Tom Hanks, Oprah, etc.? Is the commercial running nationwide or just in select regions?
6. What is your digital marketing strategy, now that you have filled the position? DTC?
7. Trials: Pediatric? Others?
8. FDA PDUFA for label change: September 30, 2017?
9. Patents: When does the Afrezza patent expire? When can we expect to see Afrezza generics?
10. In which print magazines are you going to advertise?
11. Opportunity to sell Afrezza on Amazon.
12. Financial runway: Where is the cash going to come from? Are you planning another reverse split?
13. Sales reps: What's the morale out there?
14. Script numbers: Growth trajectory? How long will it take for the company to become profitable?
15. Afrezza insurance coverage. Which tiers? Anyone not covering the drug?
16. Podcasts: Are you planning to continue those?
17. New HQ: What's the address?
18. CEO presenting at investor conferences. USA and international?
19. Are we going to have investment firm coverage again?
20. Deerfield: What are their plans?
IDEA: Create Afrezza merchandise using platforms like Zazzle, CafePress, TeeSpring, etc.